(Q42392836)

English

Diagnostic Role of (18)F-FECH-PET/CT Compared with Bone Scan in Evaluating the Prostate Cancer Patients Referring with Biochemical Recurrence

scientific article published on 28 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

Diagnostic Role of (18)F-FECH-PET/CT Compared with Bone Scan in Evaluating the Prostate Cancer Patients Referring with Biochemical Recurrence (English)

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

author name string

Mustafa Takesh

1

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

Khaldoun Odat Allh

2

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

Stefan Adams

3

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

Christian Zechmann

4

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

publication date

28 November 2012

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

2012

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

815234

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

copyright license

Creative Commons Attribution 3.0 Unported

28 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

A case of prostate cancer with disseminated carcinomatosis of bone marrow which responded to Zoledronic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

Complimentary role of FDG-PET imaging and skeletal scintigraphy in the evaluation of patients of prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

Unnecessary imaging for the staging of low-risk prostate cancer is common

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

Prostate cancer: role of SPECT and PET in imaging bone metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

Association between bone scintigraphy and serum levels of procollagen (I) and PSA in the detection of bone disease in prostate cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

PET imaging of prostate cancer using carbon-11-choline.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

28 May 2018

¹⁸F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

16 August 2018

Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

16 August 2018

The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

16 August 2018

Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

16 August 2018

In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

16 August 2018

[11C]Choline as a PET biomarker for assessment of prostate cancer tumor models.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

16 August 2018

Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515921

16 August 2018

Bone scan flare predicts successful systemic therapy for bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23251818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23251818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23251818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Correlation of procollagen (I) with prostate specific antigen and bone scan for the diagnosis of bone metastases in patients with prostate carcinoma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23251818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The flare phenomenon on radionuclide bone scan in metastatic prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23251818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.5402/2012/815234

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

29 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42392836&oldid=1944079915"